Three-year Outcomes per PD-L1 Status and Continued Cemiplimab Beyond Progression plus Chemotherapy: EMPOWER-Lung 1


Garassino M. C., Kilickap S., ÖZGÜROĞLU M., Sezer A., GÜMÜŞ M., Bondarenko I., ...More

JOURNAL OF THORACIC ONCOLOGY, no.3, 2023 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Publication Date: 2023
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Istanbul University Affiliated: No